Literature DB >> 25579693

Exercises including weight vests and a patient education program for women with osteopenia: a feasibility study of the OsteoACTIVE rehabilitation program.

Kari Anne Hakestad1, Monica Klungland Torstveit, Lars Nordsletten, Åsa Christina Axelsson, May Arna Risberg.   

Abstract

STUDY
DESIGN: Prospective case series with 1-year follow-up.
OBJECTIVES: The primary aim was to describe the OsteoACTIVE rehabilitation program and evaluate its feasibility in terms of progression, adherence, and adverse events in patients with low bone mineral density (BMD) and a healed forearm fracture. The secondary aim was to assess changes in measures of function and quality of life.
BACKGROUND: Previous studies have shown benefits of weight-bearing activities, resistance exercises, and balance and coordination training for women with low BMD and older adults. However, no studies, to our knowledge, have described or examined a rehabilitation program combining the use of weight vests and patient education in patients with low BMD.
METHODS: Forty-two postmenopausal women with osteopenia and a healed forearm fracture attended the OsteoACTIVE program for 6 months (3 sessions of 60 minutes per week). Feasibility was assessed by documenting training progression (load and exercises), program adherence (aiming for greater than 80%), and adverse events (joint pain, muscle soreness, and falls). Secondary measures included quadriceps strength, BMD, dynamic balance, walking ability, and self-report functional outcome measures. All outcome measures were recorded preintervention (baseline), postintervention, and at 1-year follow-up.
RESULTS: Thirty-five women (83%) completed the 6-month program and 31 women (74%) attended all the follow-up measurement sessions. All participants progressed during the rehabilitation program for both load and type of exercises. Furthermore, 87% of the participants met the a priori goal of 80% adherence, and no participants reported adverse events. Improvements in quadriceps strength and BMD of the femoral trochanter were noted at the end of the 6-month training period (P<.05). At 1-year follow-up, there were significant improvements in quadriceps strength and dynamic balance compared to baseline (P<.05).
CONCLUSION: The OsteoACTIVE rehabilitation program was feasible and achieved progression of training level, had high adherence, and had no adverse events. Positive improvements were established in lower extremity function and femoral trochanter BMD. Clinical trial registered at ClinicalTrials.gov (NCT01357278). LEVEL OF EVIDENCE: Therapy, level 4.

Entities:  

Keywords:  adverse events; bone mineral density; exercise; osteoporosis

Mesh:

Year:  2015        PMID: 25579693     DOI: 10.2519/jospt.2015.4842

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  3 in total

1.  Incorporating Nutrition, Vests, Education, and Strength Training (INVEST) in Bone Health: Trial Design and Methods.

Authors:  Ryan M Miller; Daniel P Beavers; Peggy M Cawthon; Charlotte Crotts; Jason Fanning; James Gerosa; Katelyn A Greene; Katherine L Hsieh; Jessica Kiel; Erica Lawrence; Leon Lenchik; S Delanie Lynch; Beverly A Nesbit; Barbara J Nicklas; Ashley A Weaver; Kristen M Beavers
Journal:  Contemp Clin Trials       Date:  2021-02-22       Impact factor: 2.226

2.  Effect of exercises with weight vests and a patient education programme for women with osteopenia and a healed wrist fracture: a randomized, controlled trial of the OsteoACTIVE programme.

Authors:  K A Hakestad; M K Torstveit; L Nordsletten; M A Risberg
Journal:  BMC Musculoskelet Disord       Date:  2015-11-14       Impact factor: 2.362

Review 3.  Adverse events and safety issues associated with physical activity and exercise for adults with osteoporosis and osteopenia: A systematic review of observational studies and an updated review of interventional studies.

Authors:  Setor K Kunutsor; Sarah Leyland; Dawn A Skelton; Laura James; Matthew Cox; Nicola Gibbons; Julie Whitney; Emma M Clark
Journal:  J Frailty Sarcopenia Falls       Date:  2018-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.